Introducing License to Cure for BioPharma – Industry Solution Experience
Dassault Systèmes License to Cure for BioPharma provides a connected and comprehensive regulatory and quality platform to accelerate therapeutic approval, production and patient adoption in a global landscape.
Download this 15 minute webinar where Compliance Consultant, Warren Perry, GRCP, covers:
- The latest trends and challenges facing the pharmaceutical and biotech industries
- How the License to Cure for BioPharma can address those challenges
- Examples of organizations that have used the capabilities of License to Cure and the benefits they have gained
Please complete the form to register and immediately view this webinar.